Advertisement

The Latest

New Hyde Park, N.Y.-based Northwell Health has appointed Matthew Weiss, MD, as senior vice president and chair of the department of surgery for Hempstead, N.Y.-based Donald and Barbara Zucker School of Medicine, New Hyde Park, N.Y.-based Long Island Jewish Medical…

Chemotherapy drugs cisplatin, carboplatin, oxaliplatin and ifosfamide are in shortage again, but five health systems are managing without the treatment delays and drug rationing that defined 2023.  Shortages of the drugs have been straining hospital supply chains since June, with…

Nashville (Tenn.) General Hospital appointed Veronica Elders, MSN, RN, as CEO. Ms. Elders had served as interim CEO before being selected by the Nashville General Hospital Authority Board, which unanimously approved her appointment following a national search led by AMN…

NewYork-Presbyterian will deploy OpenEvidence’s clinical AI tool across all of its hospitals and care sites. The tool will also be available to the New York City-based health system’s academic partners, Columbia University Vagelos College of Physicians and Surgeons and Weill…

Joe Northup, MD, associate professor of surgery at Vanderbilt University School of Medicine and director of metabolic and bariatric surgery at Vanderbilt University Medical Center in Nashville, Tenn., was elected the 40th president of the American Society for Metabolic and…

The federal government has not broadly promoted Medicare’s recent $50-a-month obesity-drug benefit, so two GLP-1 manufacturers, Eli Lilly and Novo Nordisk, are touting it themselves, according to Cost Curve.  The Medicare GLP-1 Bridge, which launched July 1, allows eligible Part…

Advertisement